The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities

CM Neophytou, M Panagi, T Stylianopoulos… - Cancers, 2021 - mdpi.com
Simple Summary Metastasis, the process by which cancer cells escape primary tumor site
and colonize distant organs, is responsible for most cancer-related deaths. The tumor …

[HTML][HTML] Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer

G Gonzalez-Avila, B Sommer… - Critical reviews in …, 2019 - Elsevier
Matrix metalloproteinases (MMPs) participate from the initial phases of cancer onset to the
settlement of a metastatic niche in a second organ. Their role in cancer progression is …

Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting

NM Abdel-Hamid, SA Abass - Molecular biology reports, 2021 - Springer
Matrix metalloproteinases (MMPs) or matrixins, are members of a zinc-dependent
endopeptidase family. They cause remodeling of the extracellular matrix (ECM) leading to …

Cell–matrix interactions: focus on proteoglycan–proteinase interplay and pharmacological targeting in cancer

AD Theocharis, C Gialeli, P Bouris… - The FEBS …, 2014 - Wiley Online Library
Proteoglycans are major constituents of extracellular matrices, as well as cell surfaces and
basement membranes. They play key roles in supporting the dynamic extracellular matrix by …

Estrogen receptor-mediated targeting of the extracellular matrix network in cancer

Z Piperigkou, NK Karamanos - Seminars in cancer biology, 2020 - Elsevier
The biological functions of estrogens are regulated by estrogen receptors (ERα and ERβ),
which contribute in the progression of several hormone-responsive cancer types via …

Heparan sulfate and heparanase as modulators of breast cancer progression

AM Gomes, MP Stelling… - BioMed Research …, 2013 - Wiley Online Library
Breast cancer is defined as a cancer originating in tissues of the breast, frequently in ducts
and lobules. During the last 30 years, studies to understand the biology and to treat breast …

[HTML][HTML] Impact of Different Anti-Hyperglycaemic Treatments on Bone Turnover Markers and Bone Mineral Density in Type 2 Diabetes Mellitus Patients: A Systematic …

MSS Saadi, R Das, A Mullath Ullas, DE Powell… - International Journal of …, 2024 - mdpi.com
Diabetic bone disease (DBD) is a frequent complication in patients with type 2 diabetes
mellitus (T2DM), characterised by altered bone mineral density (BMD) and bone turnover …

Breaching the Fortress of Tumor Microenvironment to Control Cancer Metastasis

A Jaguri, A Ahmad - Cancers, 2023 - mdpi.com
As the primary cause of death for> 90% of cancers, metastasis is the fourth and final stage of
cancer during which cells gain the ability to leave their primary site, invade surrounding …

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro

P Li, Z Zhao, L Wang, X Jin… - Experimental and …, 2018 - spandidos-publications.com
Zoledronic acid is regarded as the most potent bisphosphonate and is widely used in
patients with osteoporosis; however, its side effects, including acute‑phase reactions …

Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function

R Elsayed, P Abraham, ME Awad, Z Kurago… - Bone, 2018 - Elsevier
Unlike other antiresorptive medications, bisphosphonate molecules accumulate in the bone
matrix. Previous studies of side-effects of anti-resorptive treatment focused mainly on …